Brind.

SVA and Eledon Pharmaceuticals initiated a collaboration to evaluate tegoprubart in a clinical trial led at the University of Chicago.

1 report, 1 independent Updated Jul 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

SVA and Eledon Pharmaceuticals initiated a collaboration to evaluate tegoprubart in a clinical trial led at the University of Chicago.

Who's involved

What this event is mainly about
SVAPiotr Witkowski

Keep exploring

The entities involved

  • SVA

    Dutch company

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • GlobeNewswireSernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes Tegoprubart to be Used as Immunosuppressive Agent in Cohort C of